Table 1.
Biomarker potential validation Expression of 16 best candidate lncRNAs in whole blood samples of myocarditis (MYO) (n = 13) and acute myocardial infarction (AMI) patients (n = 10).
| lncRNA ID | MYO |
AMI |
p value | Fold change | AUC | ||
|---|---|---|---|---|---|---|---|
| Mean expression | SD | Mean expression | SD | ||||
| SEQ0194 | 1028.49 | 354.91 | 1457.80 | 400.79 | 1.21E-02 | 1.417 | 0.808 |
| SEQ0335 | 3.09 | 2.62 | 10.07 | 4.34 | 3.61E-04 | 3.265 | 0.946 |
| SEQ0446 | 19.48 | 9.47 | 6.32 | 7.86 | 4.00E-03 | 0.324 | 0.858 |
| SEQ0453 | 13.61 | 5.40 | 27.11 | 9.37 | 1.15E-03 | 1.991 | 0.885 |
| SEQ0476 | 12.11 | 12.23 | 0.26 | 0.57 | 6.47E-03 | 0.022 | 0.831 |
| SEQ0767 | 77.13 | 20.48 | 56.96 | 13.55 | 1.47E-02 | 0.738 | 0.800 |
| SEQ0867 | 107.64 | 74.36 | 50.50 | 58.97 | 1.13E-01 | 0.469 | 0.700 |
| SEQ1057 | 186.44 | 62.28 | 293.81 | 118.87 | 1.78E-02 | 1.576 | 0.792 |
| SEQ1280 | 617.00 | 224.57 | 223.83 | 285.14 | 6.70E-03 | 0.363 | 0.838 |
| SEQ1344 | 3.71 | 2.57 | 9.59 | 5.76 | 3.24E-03 | 2.587 | 0.854 |
| SEQ1599 | 22.06 | 7.21 | 35.15 | 10.77 | 8.62E-04 | 1.593 | 0.892 |
| SEQ2161 | 17.56 | 3.71 | 12.60 | 5.73 | 6.47E-03 | 0.718 | 0.831 |
| SEQ2164 | 136.19 | 49.14 | 53.53 | 61.81 | 5.55E-03 | 0.393 | 0.846 |
| SEQ2556 | 8.20 | 4.08 | 4.19 | 3.34 | 3.76E-02 | 0.511 | 0.762 |
| SEQ2585 | 4.20 | 2.71 | 8.01 | 3.43 | 1.21E-02 | 1.910 | 0.808 |
| SEQ2725 | 1.59 | 2.70 | 5.91 | 5.22 | 3.85E-02 | 3.714 | 0.746 |